As part of one of the best developmental therapeutics programs in the country, our clinical pharmacologists conduct more clinical trials than any pediatric cancer center in the nation and are leaders in the development of new chemotherapy treatments for pediatric cancer.
More than 260 treatment studies
Texas Children's Cancer and Hematology Centers have more than 260 clinical trials underway to determine the safety and effectiveness of drug treatments in children. Approximately, 80% of our patients are involved in clinical trials. Frequently asked questions about clinical trials
The newest and most advanced therapies
Our Developmental Therapeutics Program has developed a number of new anti-cancer agents currently undergoing clinical trials within the Cancer Center, which means our patients have access to the newest and most advanced therapies. Learn about our Phase I Developmental Therapeutics Clinic
Every patient is considered for leading-edge therapies
Recognizing that clinical trials are the standard of care for all children with cancer, every eligible patient is considered for entry in National Cancer Institute-approved trials, and the vast majority are registered in these studies. These treatment protocols represent leading-edge therapies in the field, to provide the best treatments for children with cancer.
Supported by the National Institutes of Health
Many of the clinical trials performed at Texas Children's Cancer Center are supported in part by the hospital's National Institutes of Health-supported Clinical Research Center (CRC).